Table 3.
Comparisons of short-term outcomes between patients with and without persistent inflammation
| Short-term outcomes | Persistent inflammation | p value | RR | 95%CI | |
|---|---|---|---|---|---|
| With | Without | ||||
| Pulmonary infection | 21 (77.8) | 23 (46) | 0.009* | 1.7 | 1.2–2.4 |
| Urinary tract infection | 3 (11.1) | 6 (12) | 1 | – | – |
| 1-month mortality | 8 (30) | 2 (4) | 0.003* | 7.7 | 1.8–33.6 |
| 1-month mRS | 5 (4–6)a | 3 (2–4)a | 0.0005* | – | – |
| 3-month mRS | 3 (2–6) a | 2 (1–3) a | 0.139 | – | – |
Abbreviations: mRS modified Rankin scale; RR elative risk; CI confidence interval
Unless specified, values are p values in non-parametric tests and values are numbers of patients (%)
aMedian (interquartile range)
*Statistically significant